£4.5M Investment Led by Confluent Medical
Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »
Corneal Case Study
Read how close partnership with our client helped overcome technological & pandemic challenges.
MedCity Company of the Month
Each month MedCity profiles an innovative, growing company from across the Greater South East of England. The Electrospinning Company is a pioneer in design and manufacture of implantable biomaterials and they have recently expanded into purpose-built cleanroom facilities at the Harwell Campus to increase their production capabilities. We spoke with Ann Kramer, CEO, about their work… Read more »